Acetilcisteína: Una actualización clínica y farmacológica sobre su efecto mucolítico. Estudio de revisión / Acetylcisteine. A clinical and pharmacological actualization with special. Reference to its mucolytic efect
Prensa méd. argent
; 105(10): 667-677, oct 2019. fig, graf
Article
de Es
| BINACIS, LILACS
| ID: biblio-1025940
Bibliothèque responsable:
AR392.1
ABSTRACT
The authors present a clinical and farmacological evaluation of the effect and safety of N-acetylcysteine in chronic obstructive diseases. The N-actylcysteine (NAC) is a sulphorated amino acid employed as an mucolytic agent. The efficacy and tolerability of oral NAC as compared with other agents was determined, in the mucolytic treatment on mucus hypersecretion and in the management of respiratory tract fluids and sputums from cigarette smokers, and also as a bronchial mucus fluidifying agent. A sistematic review and analysis of the effect of NAC and its effectiveness. In the treatment of acute respiratory disorders in children was determined
Indice:
LILACS
Sujet Principal:
Acétylcystéine
/
Bromhexine
/
Muqueuse respiratoire
/
Mucus
Limites du sujet:
Humans
langue:
Es
Texte intégral:
Prensa méd. argent
Thème du journal:
MEDICINA
Année:
2019
Type:
Article